Denavir (New American Therapeutics, Inc)
Welcome to the PulseAid listing for the Denavir drug offered from New American Therapeutics, Inc. This DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | New American Therapeutics, Inc |
| NON-PROPRIETARY NAME: | penciclovir |
| SUBSTANCE NAME: | PENCICLOVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-12-29 |
| END MARKETING DATE: | 0000-00-00 |
Denavir HUMAN PRESCRIPTION DRUG Details:
| Item Description | Denavir from New American Therapeutics, Inc |
| LABELER NAME: | New American Therapeutics, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/g) |
| START MARKETING DATE: | 2010-12-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50816-624_3a3aa611-f531-489a-99c7-2fbad3b04f86 |
| PRODUCT NDC: | 50816-624 |
| APPLICATION NUMBER: | NDA020629 |
Other PENCICLOVIR Pharmaceutical Manufacturers / Labelers:
